Krónikus vesebetegség: vizsgálatok itt: Belgium
10 of 14 trials · From ClinicalTrials.gov, checked 2026. november 18.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleA Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
- Where
- Aalst, Genk, Hasselt, Ieper, Jette, Kortrijk, Leuven, Liège, Mechelen, Namur, Roeselare, Ronse, Sint-Lambrechts-Woluwe
- Életkor
- 18 év and over
- People
- 5000 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06742723 · EU 2023-506460-14-00 - 3. fázisTaking peopleA Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease (ATTAIN-Outcomes)
- Where
- Brasschaat, Genk, Hasselt, Ieper, Kluisbergen, Kortrijk, Leuven, Louvière, Mechelen, Ostend, Putte, Roeselare, Sint-Lambrechts-Woluwe
- Életkor
- 50 év and over
- People
- 7140 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07241390 · EU 2025-523123-22-00 - No phaseTaking peopleStreamlined Denervation With spYral For an Optimized Treatment (SPYRAL SWYFT) in Subjects With Uncontrolled Hypertension
- Where
- Aalst, Bruges, Genk, Ghent, Liège
- Életkor
- 18 év and over
- People
- 130 worldwide
- Run by
- Medtronic Vascular
See details and how to joinNCT07115953 - 1. fázisTaking peopleStudy of 3 Monoclonal Antibodies (REGN9933, REGN7508, and REGN9533) in Adult Participants With End-Stage Kidney Disease on Hemodialysis
- Where
- Ghent
- Életkor
- 18 év and over
- People
- 36
- Run by
- Regeneron Pharmaceuticals
See details and how to joinNCT07759167 · EU 2026-525844-14-00 - 3. fázisFut, nem toborozA Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label Iptacopan/LNP023 in Participants With Primary IgA Nephropathy
- Where
- Edegem, Leuven, Roeselare
- Életkor
- 18 év to 100 év
- People
- 540 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT04557462 · EU 2023-508690-92-00 - 3. fázisFut, nem toborozA Study to Learn More About How Safe the Study Treatment Finerenone is in Long-term Use When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker Over 18 Months of Use in Children and Young Adults From 1 to 18 Years of Age With Chronic Kidney Disease and Proteinuria
- Where
- Brussels, Gent, Leuven, Liège, Sint-Lambrechts-Woluwe
- Életkor
- 1 év to 18 év
- People
- 100 worldwide
- Run by
- Bayer
See details and how to joinNCT05457283 · EU 2023-504885-50-00 - 2/3. fázisTaking peopleCombined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
- Where
- Aalst, Bonheiden, Charleroi, Ghent, La Louvière, Leper, Leuven, Liège, Roeselare, Sint-Niklaas
- Életkor
- 18 év and over
- People
- 3110 worldwide
- Run by
- CSL Behring
See details and how to joinNCT05485961 · EU 2022-500273-14-00 - 3. fázisBefejeződöttA Phase 3 Study of Etelcalcetide in Children With Secondary Hyperparathyroidism Receiving Hemodialysis
- Where
- Gent
- Életkor
- 2 év to 17 év
- People
- 24 worldwide
- Run by
- Amgen
See details and how to joinNCT03969329 · EU 2023-506471-10-00 - No phaseTaking peopleBenefits of a Renal Rehabilitation Program Adapted to Uremic Patients on Daily Hemodialysis at Low Dialysate Flow Rate.
- Where
- Brussels
- Életkor
- 18 év and over
- People
- 50
- Run by
- Brugmann University Hospital
See details and how to joinNCT07413315 - No phaseTaking peopleEffect of Modifying Magnesium Concentration in Citrate-enriched Dialysate on Hemodialysis-associated Thromboinflammation
- Where
- Brussels
- Életkor
- 18 év and over
- People
- 15
- Run by
- Universitair Ziekenhuis Brussel
See details and how to joinNCT07206524